SURF - Surface Oncology - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

SURF is currently covered by 3 analysts with an average potential upside of $6.75 (184.08%) from yesterday's end of day stock price of $1.07. Surface Oncology activity chart has currently 1 price targets and 5 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.33% with an average time for these price targets to be met of 89.67 days.

Highest price target for SURF is $1, Lowest price target is $1, average price target is $1.

Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 20-Jun-2023. First documented stock forecast 28-Aug-2020.

Best performing analysts who are covering SURF - Surface Oncology:

Robert Driscoll Swayampakula Ramakanth Justin Zelin

Currently, out of the existing stock ratings of SURF - 3 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

3

5 months 19 days ago

1/5 (20%)

$7.15 (162.91%)

140

Buy

5

$3.93 (367.29%)

11

5 months 19 days ago

1/2 (50%)

$4.55 (288.38%)

129

Buy

17

1 years 1 months 6 days ago

0/1 (0%)

$8.54 (100.95%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SURF (Surface Oncology) average time for price targets to be met?

On average it took 89.67 days on average for the stock forecasts to be realized with a an average price target met ratio 23.33

Which analyst has the current highest performing score on SURF (Surface Oncology) with a proven track record?

ROBERT DRISCOLL

Which analyst has the current lower performing score on SURF (Surface Oncology) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on SURF (Surface Oncology)?

Robert Driscoll works at WEDBUSH and has 10 price targets and 7 ratings on SURF

Which analyst is the currently most bullish on SURF (Surface Oncology)?

Swayampakula Ramakanth with highest potential upside - $3.93

Which analyst is the currently most reserved on SURF (Surface Oncology)?

Robert Driscoll with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart